Activation of Notch signaling is required for cholangiocarcinoma progression and is enhanced by inactivation of p53 in vivo.
<h4>Unlabelled</h4>Cholangiocacinoma (CC) is a cancer disease with rising incidence. Notch signaling has been shown to be deregulated in many cancers. However, the role of this signaling pathway in the carcinogenesis of CC is still not fully explored. In this study, we investigated the e...
Guardado en:
Autores principales: | Mona El Khatib, Przemyslaw Bozko, Vindhya Palagani, Nisar P Malek, Ludwig Wilkens, Ruben R Plentz |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/af72240344ee4beda97e4828529303f7 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Capsaicin treatment attenuates cholangiocarcinoma carcinogenesis.
por: Annika Wutka, et al.
Publicado: (2014) -
Epithelial mesenchymal transition and pancreatic tumor initiating CD44+/EpCAM+ cells are inhibited by γ-secretase inhibitor IX.
por: Vindhya Palagani, et al.
Publicado: (2012) -
Retinal regeneration requires dynamic Notch signaling
por: Leah J Campbell, et al.
Publicado: (2022) -
Inactivation and inducible oncogenic mutation of p53 in gene targeted pigs.
por: Simon Leuchs, et al.
Publicado: (2012) -
Oncogenic KRAS Requires Complete Loss of BAP1 Function for Development of Murine Intrahepatic Cholangiocarcinoma
por: Rebecca Marcus, et al.
Publicado: (2021)